BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 9758363)

  • 1. Performance of liquid-based, thin-layer cervical cytology: correlation with reference diagnoses and human papillomavirus testing.
    Sherman ME; Mendoza M; Lee KR; Ashfaq R; Birdsong GG; Corkill ME; McIntosh KM; Inhorn SL; Zahniser DJ; Baber G; Barber C; Stoler MH
    Mod Pathol; 1998 Sep; 11(9):837-43. PubMed ID: 9758363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utility of liquid-based cytology for cervical carcinoma screening: results of a population-based study conducted in a region of Costa Rica with a high incidence of cervical carcinoma.
    Hutchinson ML; Zahniser DJ; Sherman ME; Herrero R; Alfaro M; Bratti MC; Hildesheim A; Lorincz AT; Greenberg MD; Morales J; Schiffman M
    Cancer; 1999 Apr; 87(2):48-55. PubMed ID: 10227593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative analysis of a liquid-based Pap test and concurrent HPV DNA assay of residual samples. A study of 608 cases.
    Hong IS; Marshalleck J; Williams RH; Gaiter TE; Mielzynska-Lohnas I; Kim K
    Acta Cytol; 2002; 46(5):828-34. PubMed ID: 12365215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of human papillomavirus testing in primary screening for cervical abnormalities: comparison of sensitivity, specificity, and frequency of referral.
    Kulasingam SL; Hughes JP; Kiviat NB; Mao C; Weiss NS; Kuypers JM; Koutsky LA
    JAMA; 2002 Oct; 288(14):1749-57. PubMed ID: 12365959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human papillomavirus testing and liquid-based cytology: results at recruitment from the new technologies for cervical cancer randomized controlled trial.
    Ronco G; Segnan N; Giorgi-Rossi P; Zappa M; Casadei GP; Carozzi F; Dalla Palma P; Del Mistro A; Folicaldi S; Gillio-Tos A; Nardo G; Naldoni C; Schincaglia P; Zorzi M; Confortini M; Cuzick J;
    J Natl Cancer Inst; 2006 Jun; 98(11):765-74. PubMed ID: 16757701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness of alternative triage strategies for atypical squamous cells of undetermined significance.
    Kim JJ; Wright TC; Goldie SJ
    JAMA; 2002 May; 287(18):2382-90. PubMed ID: 11988059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human papillomavirus testing versus repeat cytology for triage of minor cytological cervical lesions.
    Arbyn M; Roelens J; Simoens C; Buntinx F; Paraskevaidis E; Martin-Hirsch PP; Prendiville WJ
    Cochrane Database Syst Rev; 2013 Mar; 2013(3):CD008054. PubMed ID: 23543559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A thin-layer, liquid-based pap test for mass screening in an area of China with a high incidence of cervical carcinoma. A cross-sectional, comparative study.
    Pan Q; Belinson JL; Li L; Pretorius RG; Qiao YL; Zhang WH; Zhang X; Wu LY; Rong SD; Sun YT
    Acta Cytol; 2003; 47(1):45-50. PubMed ID: 12585030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection Rate of High-Grade Cervical Neoplasia and Cost-Effectiveness of High-Risk Human Papillomavirus Genotyping with Reflex Liquid-based Cytology in Cervical Cancer Screening.
    Tay SK; Lin LE; Goh RC
    Ann Acad Med Singap; 2017 Jul; 46(7):267-273. PubMed ID: 28821890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cervical specimens collected in liquid buffer are suitable for both cytologic screening and ancillary human papillomavirus testing.
    Sherman ME; Schiffman MH; Lorincz AT; Herrero R; Hutchinson ML; Bratti C; Zahniser D; Morales J; Hildesheim A; Helgesen K; Kelly D; Alfaro M; Mena F; Balmaceda I; Mango L; Greenberg M
    Cancer; 1997 Apr; 81(2):89-97. PubMed ID: 9126136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study.
    Castle PE; Stoler MH; Wright TC; Sharma A; Wright TL; Behrens CM
    Lancet Oncol; 2011 Sep; 12(9):880-90. PubMed ID: 21865084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liquid-based cytology and human papillomavirus testing to screen for cervical cancer: a systematic review for the U.S. Preventive Services Task Force.
    Whitlock EP; Vesco KK; Eder M; Lin JS; Senger CA; Burda BU
    Ann Intern Med; 2011 Nov; 155(10):687-97, W214-5. PubMed ID: 22006930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Combining high-risk human papillomavirus DNA test and cytological test to detect early cervical dysplasia].
    Qian DY; Cen JM; Wang D; Zeng RH; Lin AH; Shu YH; Hong DH; Huang ZH
    Zhonghua Fu Chan Ke Za Zhi; 2006 Jan; 41(1):34-7. PubMed ID: 16635326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of features indicating progression in atypical squamous cells with undetermined significance: human papillomavirus typing and DNA ploidy analysis from liquid-based cytologic samples.
    Bollmann R; Méhes G; Torka R; Speich N; Schmitt C; Bollmann M
    Cancer; 2003 Apr; 99(2):113-7. PubMed ID: 12704691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cross sectional study of conventional cervical smear, monolayer cytology, and human papillomavirus DNA testing for cervical cancer screening.
    Coste J; Cochand-Priollet B; de Cremoux P; Le Galès C; Cartier I; Molinié V; Labbé S; Vacher-Lavenu MC; Vielh P;
    BMJ; 2003 Apr; 326(7392):733. PubMed ID: 12676841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of Pap smear, cervical biopsy, and clinical follow-up with an HPV typing microarray system.
    Nuovo GJ; Bartholomew D; Jung WW; Han IK; Um T; Grabarz DF; Lee DJ; McCabe RT
    Diagn Mol Pathol; 2008 Jun; 17(2):107-11. PubMed ID: 18382353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Introduction of liquid-based cytology and human papillomavirus testing in cervical cancer screening in Luxembourg.
    Latsuzbaia A; Hebette G; Fischer M; Arbyn M; Weyers S; Vielh P; Schmitt F; Mossong J
    Diagn Cytopathol; 2017 May; 45(5):384-390. PubMed ID: 28247516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Results at recruitment from a randomized controlled trial comparing human papillomavirus testing alone with conventional cytology as the primary cervical cancer screening test.
    Ronco G; Giorgi-Rossi P; Carozzi F; Confortini M; Dalla Palma P; Del Mistro A; Gillio-Tos A; Minucci D; Naldoni C; Rizzolo R; Schincaglia P; Volante R; Zappa M; Zorzi M; Cuzick J; Segnan N;
    J Natl Cancer Inst; 2008 Apr; 100(7):492-501. PubMed ID: 18364502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age-specific evaluation of primary human papillomavirus screening vs conventional cytology in a randomized setting.
    Leinonen M; Nieminen P; Kotaniemi-Talonen L; Malila N; Tarkkanen J; Laurila P; Anttila A
    J Natl Cancer Inst; 2009 Dec; 101(23):1612-23. PubMed ID: 19903804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reflex human papilloma virus infection testing detects the same proportion of cervical intraepithelial neoplasia grade 2-3 in young versus elderly women.
    Eltoum IA; Chhieng DC; Roberson J; McMillon D; Partridge EE
    Cancer; 2005 Aug; 105(4):194-8. PubMed ID: 15900575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.